[1] 劳剑辉,黄纯英.452例老年患者医院感染影响因素分析[J]. 广州医药,2015,46(2):76-79.
[2] CHARPENTIER J, LUYT CE, FULLA Y, et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis[J]. Crit Care Med, 2004, 32(3): 660-665.
[3] VER EK, SPAPEN HD, NGUYEN DN, et al. Cardiac troponins I and Tare biological markers of left ventricular dysfunction in septic shock[J]. Clin Chem, 2000, 46(5): 650-657.
[4] BESSIERE F, KHENIFER S, DUBOURG J, et al. Prognostic value of troponins in sepsis: a meta-analysis[J]. Intensive Care Med, 2013,39(7): 1181-1189.
[5] POST F, WEILEMANN LS, MESSOW CM, et al. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients[J]. Crit Care Med, 2008, 36(11): 3030-3037.
[6] BOUHEMAD B, NICOLAS-ROBIN A, ARBELOT C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction[J].Crit Care Med, 2009, 37(2): 441-447.
[7] DELLINGER RP,MITCHELL M. LEVY,ANDREW RHODES,et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med[J]. 2013,41(2):580-637.
[8] MOAMMAR MQ,ALI MI,MAHMOOD MA,et al Cardiac troponin I levelsand alveolararterial oxygen gradient in patients with community-acquiredpneumonia[J]. Heaet Lung Circ,2010,19(2): 90-92.
[9] LABUGGER R, ORGAN L,COLLIER C,et al. Extensivet roponin I and T modification detected in serum from patients with AMI[J]. Circulation,2000,102(11):1221-1226.
[10] ZANOTTI-CAVAZZONI SL, HOLLENBERG SM. Cardiac dysfunction insevere sepsis and septic shock[J]. Curr Opin Crit Care, 2009, 15(5):392-397.
[11] KLOUCHE K, POMMET S, AMIGUES L, et al. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock:relationships with systolic myocardial dysfunction and intensive careunit mortality[J]. J Intensive Care Med, 2013, 29(4): 229-237. |